Viking Therapeutics
VKTX
#3876
Rank
โ‚ฌ3.03 B
Marketcap
23,79ย โ‚ฌ
Share price
0.08%
Change (1 day)
-27.05%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2026 (TTM): -โ‚ฌ0.55 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ0.33 Billion a decrease over its 2024 earnings that were of -โ‚ฌ99.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.55 Billion66.83%
2025 -โ‚ฌ0.33 Billion227.05%
2024 -โ‚ฌ99.87 Million28.02%
2023 -โ‚ฌ78.01 Million24.73%
2022 -โ‚ฌ62.55 Million25.24%
2021 -โ‚ฌ49.95 Million39.23%
2020 -โ‚ฌ35.87 Million53.21%
2019 -โ‚ฌ23.42 Million16.84%
2018 -โ‚ฌ20.04 Million7.22%
2017 -โ‚ฌ18.69 Million39.68%
2016 -โ‚ฌ13.38 Million-37.05%
2015 -โ‚ฌ21.26 Million6.94%
2014 -โ‚ฌ19.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.41 Billion-28.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ27.86 M-104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ3.41 M-100.60%๐Ÿ‡บ๐Ÿ‡ธ USA